Abstract

Rift Valley fever virus (RVFV) is a mosquito-borne virus in the family Bunyaviridiae that has spread throughout continental Africa to Madagascar and the Arabian Peninsula. The establishment of RVFV in North America would have serious consequences for human and animal health in addition to a significant economic impact on the livestock industry. Published and unpublished data on RVFV vector competence, vertebrate host competence, and mosquito feeding patterns from the United States were combined to quantitatively implicate mosquito vectors and vertebrate hosts that may be important to RVFV transmission in the United States. A viremia-vector competence relationship based on published mosquito transmission studies was used to calculate a vertebrate host competence index which was then combined with mosquito blood feeding patterns to approximate the vector and vertebrate amplification fraction, defined as the relative contribution of the mosquito or vertebrate host to pathogen transmission. Results implicate several Aedes spp. mosquitoes and vertebrates in the order Artiodactyla as important hosts for RVFV transmission in the U.S. Moreover, this study identifies critical gaps in knowledge which would be necessary to complete a comprehensive analysis identifying the different contributions of mosquitoes and vertebrates to potential RVFV transmission in the U.S. Future research should focus on (1) the dose-dependent relationship between viremic exposure and the subsequent infectiousness of key mosquito species, (2) evaluation of vertebrate host competence for RVFV among North American mammal species, with particular emphasis on the order Artiodactyla, and (3) identification of areas with a high risk for RVFV introduction so data on local vector and host populations can help generate geographically appropriate amplification fraction estimates.

Highlights

  • Rift Valley fever virus (RVFV) is an emerging infectious disease in Africa and the Middle East

  • The most competent transmission vectors of RVFV when exposed to 107.5 plaque-forming units/ml (PFU/ml) of viremia are estimated to be Coquillettidia perturbans (Walker) (0.38), Ae. japonicus japonicus (Theobald) (0.37), Cx. tarsalis (0.33), and Ae. excrucians (0.28)

  • Host competence To estimate vertebrate host competence, published data and unpublished data provided by Dr John Morrill from RVFV experimental infections (Figure 1) [39,40,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65] were inserted into a viremia-vector competence equation that describes the relative number of infectious mosquitoes resulting from feeding on a vertebrate host (Figure S1, C)

Read more

Summary

Introduction

Rift Valley fever virus (RVFV) is an emerging infectious disease in Africa and the Middle East. If introduced to North America, RVFV is capable of serious health and socioeconomic consequences potentially incapacitating large numbers of humans, decimating susceptible farm animals, and instigating heavy restrictions on livestock trade [1,2]. In 1931, RVFV was first reported in Kenya. It spread to Egypt in 1977 and was detected on the Arabian Peninsula in 2000 [6,7]. Since advancing beyond African borders in 2000, total human cases of RVFV include 768 confirmed fatalities, 4,248 confirmed infections and over 75,000 suggested unconfirmed cases [8,9,10,11,12,13,14,15]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call